Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics
- PMID: 40482637
- PMCID: PMC12279385
- DOI: 10.1016/j.neuron.2025.05.014
Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics
Abstract
Huntington's disease (HD) is marked by widespread cellular dysregulation. To understand disease mechanisms, we and others have utilized bulk and single-cell transcriptomics, which provide cell-type information but limited spatial information. We used 10× Genomics Visium spatial transcriptomics integrated with matched single-nuclei RNA sequencing (snRNA-seq) in the rapidly progressing HD R6/2 mouse brain (post-natal day 0 [P0], 4 weeks, and 12 weeks). Our data suggest regional, temporal, and cell-type-specific regulatory pathways that establish distinct gene expression changes. Synaptic dysfunction is observed broadly throughout the brain, whereas we observed early dysregulation of the transcription factor 4 (Tcf4) that may drive cortical changes. Mitochondrial deficits are the earliest changes, beginning at P0 in the striatum. Striatal identity genes show early increased expression that becomes progressively downregulated. Finally, we identified a time-dependent dysregulation of neuropeptide Y signaling and potential interaction with the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway, which may be involved in the imbalance between Drd1 and Drd2 neuron vulnerability.
Keywords: Huntington’s disease; R62 transgenic; cell-cell signaling; metabolism; neuropeptide Y; protein kinase A; snRNA-seq; spatial transcriptomics; transcription factor 4; transcriptional dysregulation.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Compromised retinoic acid receptor beta expression accelerates the onset of motor, cellular and molecular abnormalities in a mouse model of Huntington's disease.Neurobiol Dis. 2025 Aug;212:106943. doi: 10.1016/j.nbd.2025.106943. Epub 2025 May 13. Neurobiol Dis. 2025. PMID: 40348200
-
Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease.Neurobiol Dis. 2025 Jan;204:106752. doi: 10.1016/j.nbd.2024.106752. Epub 2024 Dec 5. Neurobiol Dis. 2025. PMID: 39644979
-
Estrogen-related receptor gamma is a regulator of mitochondrial, autophagy, and immediate-early gene programs in spiny projection neurons: Relevance for transcriptional changes in Huntington disease.Neurobiol Dis. 2025 Mar;206:106818. doi: 10.1016/j.nbd.2025.106818. Epub 2025 Jan 28. Neurobiol Dis. 2025. PMID: 39884587 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Multiscale information processing in the immune system.Front Immunol. 2025 Jul 21;16:1563992. doi: 10.3389/fimmu.2025.1563992. eCollection 2025. Front Immunol. 2025. PMID: 40761781 Free PMC article. Review.
References
-
- Scahill RI, Zeun P, Osborne-Crowley K, Johnson EB, Gregory S, Parker C, Lowe J, Nair A, O’Callaghan C, Langley C, et al. (2020). Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington’s disease Young Adult Study (HD-YAS): a cross-sectional analysis. The Lancet Neurology 19. 502–512. 10.1016/S1474-4422(20)30143-5. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases